Results 21 to 30 of about 9,427 (93)

Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability [PDF]

open access: yesEMBO Molecular Medicine
Collecting duct carcinoma (CDC) is an aggressive rare subtype of kidney cancer with unmet clinical needs. Little is known about its underlying molecular alterations and etiology, primarily due to its rarity, and lack of preclinical models.
Peiyong Guan   +27 more
doaj   +2 more sources

Urothelial Carcinoma of the Renal Pelvis with Synchronous Ipsilateral Collecting Duct Carcinoma: Two Case Reports [PDF]

open access: yesJournal of the Korean Society of Radiology
Synchronous renal malignancies are seldom encountered or diagnosed post-renal resection. A combination of renal cell carcinoma (RCC) and urothelial carcinoma (UC) is most commonly reported.
Sang Bin Bae   +2 more
doaj   +2 more sources

Bellini Duct Carcinoma: A Rare Entity [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Bellini duct carcinoma of kidney derives from collecting duct and is associated with an aggressive course and extremely poor prognosis. Here, we report an interesting case of Collecting Duct Carcinoma (CDC) with Inferior Vena Cava (IVC) thrombus and ...
Amit Kumar Mishra   +4 more
doaj   +1 more source

Collecting Duct Carcinoma: A Rare Entity

open access: yesQanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya, 2020
Collecting duct carcinoma is a rare and highly aggressive subtype of renal cell carcinoma. The incidence rate is less than 1-2% of all renal tumors and usually, affect middle-aged adult, commonly in men.
Ferdinant Martinus Djawa   +1 more
doaj   +1 more source

Aggressive co-existence: Collecting duct and clear cell carcinoma in the same kidney

open access: yesUrology Research and Practice, 2019
As in every organ, synchronous multiple cancers are rarely encountered in kidneys. In the literature, mostly co-existence of renal cell carcinoma and transitional cell carcinoma was reported.
Abdullah Hızır Yavuzsan   +3 more
doaj   +1 more source

Collecting duct carcinoma: A rare renal tumor

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2012
The most common primary malignant renal tumor is renal cell carcinoma (RCC), which accounts for 3% of all adult malignancies. Bellini duct carcinoma or collecting duct carcinoma is an unusual rare variant of RCC.
Punit Bansal   +3 more
doaj   +1 more source

Collecting duct carcinoma associated with oncocytoma

open access: yesInternational Brazilian Journal of Urology, 2005
Collecting duct carcinoma (CDC) is a rare, highly aggressive malignant neoplasm that arises from the collecting duct epithelium of the kidney. CDC was reported to coexist with renal cell and transitional cell carcinomas.
George M. Yousef   +3 more
doaj   +1 more source

Metastatic collecting duct carcinoma of the kidney treated with sunitinib

open access: yesWorld Journal of Surgical Oncology, 2011
Collecting duct carcinoma (CDC) of the kidney is a rare and aggressive malignant tumor arising from the distal collecting tubules which has been shown to have a poor response to several kinds of systemic therapy.
M'rabti Hind   +5 more
doaj   +1 more source

Carcinoma renal dos ductos de Bellini

open access: yesRevista do Colégio Brasileiro de Cirurgiões
Two types primary epithelial tumours of the kidney have been distinguished, such as renal cell carcinoma (hypernephroma or Grawitz) deriving from proximal tubules and carcinoma arising in the urothelium of the kidney's collecting system. Mancilla-Jimenez
Helio Begliomini
doaj   +1 more source

Tubulocystic Carcinoma of the Kidney: A Case Report of Natural History and Long-Term Follow-Up

open access: yesThe Scientific World Journal, 2010
Tubulocystic carcinoma (TC) is a rare primary renal tumor that has been recently described in the pathology literature. Formerly termed low-grade collecting duct carcinoma, further molecular analysis has shown TC to be a distinct entity that is separate ...
Kelvin A. Moses   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy